Exelixis Inc. (United States) is listed on the Nasdaq and has a market capitalization of $16.97 billion, with shareholders equity totaling $1.83 billion.
The company employs approximately 773 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Exelixis Inc. reported $2.50 billion in revenue, generating net income of $885.14 million.
Key financial metrics include a P/E ratio of 19.18, a price-to-book (P/B) ratio of 9.26, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker EXEL.